Cover Image
市場調查報告書

脂肪乳劑的中國市場

Investigation Report on China Fat Emulsion Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 338987
出版日期 內容資訊 英文 40 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
脂肪乳劑的中國市場 Investigation Report on China Fat Emulsion Market, 2010-2019
出版日期: 2015年09月07日 內容資訊: 英文 40 Pages
簡介

脂肪乳劑以大豆油的乳劑、蛋黃磷脂質、甘油營養成分為原料,用於供給必需脂肪酸給飲食中無法補充的人。西方各國從1961年開始使用,中國自1983年上市。以往因產品單價高而妨礙普及,不過,隨著可支配所得的上升,及惡性癌症、心血管疾病等患者數增加,預計今後需求將擴大。調查對象醫院的脂肪乳劑的銷售額,2005年為3億人民幣,2014年為9億人民幣,2005∼2014年的年複合成長率(CAGR) 達到14%以上。

本報告提供中國的脂肪乳劑的市場相關分析、脂肪乳劑的特徵和認證情形、市場整體規模、各企業/各劑型的市場佔有率、價格趨勢、主要製造商簡介、今後的市場成長預測等調查評估。

第1章 RemiFentanyl的相關概念

  • 適應症
  • 全球市場的銷售情形

第2章 中國的脂肪乳劑市場簡介

  • 中國國內的脂肪乳劑的專利申請、核準情況
  • 主要製造商
  • 市場規模

第3章 中國國內的脂肪乳劑銷售額分析 (過去5年份)

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售量

第4章 脂肪乳劑的主要廠商的市場佔有率 (過去5年份)

  • 市場佔有率 (以金額為準)
  • 市場佔有率 (以數量為準)

第5章 中國國內的脂肪乳劑的劑型 (過去5年份)

  • 各劑型的市場佔有率 (以金額為準)
  • 各劑型的市場佔有率 (以數量為準)

第6章 中國醫院的脂肪乳劑的參照價格

  • Baxter Healthcare (Guangzhou) Co., Ltd
  • Sino-Swed Pharmaceutical Corp. Ltd
  • Chongqing Pharscin Pharmaceutical Co., Ltd
  • Fresenius Kabi (Sweden) Co., Ltd
  • Fresenius Kabi (Austria) Co., Ltd

第7章 中國國內的脂肪乳劑的主要製造商 (過去5年份)

  • Baxter Healthcare (Guangzhou) Co., Ltd
  • Sino-Swed Pharmaceutical Corp. Ltd
  • Fresenius Kabi (Sweden) Co., Ltd
  • B.Braun AG (德國)

第8章 中國國內的脂肪乳劑市場未來展望 (今後5年份)

  • 市場規模的預測
  • 競爭環境的預測

圖表一覽

目錄
Product Code: 1509316

As an emulsion of soy bean oil, egg phospholipids and glycerin, fat emulsion injection provides essential fatty acids for people who are unable to get nutrition via an oral diet.

The concept of fat emulsion dated back to the 1960s when hospitals in advanced countries found soy bean oil with its oleic acid and linoleic acid to be an ideal component of intravenous nutrition for critically ill patients like those who suffer from serious burn or advanced tumor and dyscrasia or those who had car accident or major surgery. Ever since 1961 when Interlipid, a soybean oil fat emulsion injection, was developed by scientists with Fresenius Kabi (Sweden) Co., Ltd, it has remained the best-selling injection. In 1983, Sino-Swed Pharmaceutical Corp. Ltd introduced raw material and patented technology from Fresenius Kabi (Sweden) Co., Ltd to produce Interlipid. In the mid-1980s, such western giants as Fresenius Company developed medium- and long-chain fatty acid injection with fewer adverse effects which was included by the National Health and Family Planning Commission of the People's Republic of China into the national medicare drug list as early as a decade ago.

The wide application of fat emulsion has been limited by its high unit price of CNY 80 despite an annual sales volume of over 10 million in recent years. But with rising ability to pay and increasing incidence of such diseases as malignant cancer, cardiovascular diseases and respiratory diseases caused by environmental pollution and lifestyle changes, the demand for fat emulsion will keep going up.

According to CRI's market survey, the sales value of fat emulsion in sample hospitals rose from less than CNY 300 million in 2005 to over CNY 900 million in 2014 and CAGR during this period surpassed 14%.

As Chinese people's capability to pay rises, fat emulsion, a component of intravenous nutrition, with its wide application in clinical practice, has witnessed a growing market and therefore good market prospects.

Readers can get at least the following information through this report:

  • market size of fat emulsion in China
  • competitive landscape of fat emulsion market in China
  • price of fat emulsion made by different enterprises in China
  • market outlook of fat emulsion in China

The author suggests the following groups of people purchase this report:

  • Pharmaceutical Manufacturers
  • investors/research institutions interested in Chinese medicine market
  • any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Fat Emulsion

  • 1.1. Indication
  • 1.2. Overview of Global Market

2. Market Profile of Fat Emulsion in China

  • 2.1. Patent and Approval Information of Fat Emulsion in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Fat Emulsion Sales in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Fat Emulsion Manufacturers in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Fat Emulsion in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Fat Emulsion in Chinese Hospitals in 2014

  • 6.1. Baxter Healthcare (Guangzhou) Co., Ltd
  • 6.2. Sino-Swed Pharmaceutical Corp. Ltd
  • 6.3. Chongqing Pharscin Pharmaceutical Co., Ltd
  • 6.4. Fresenius Kabi (Sweden) Co., Ltd
  • 6.5. Fresenius Kabi (Austria) Co., Ltd

7. Major Manufacturers of Fat Emulsion in Chinese Market, 2010-2014

  • 7.1. Baxter Healthcare (Guangzhou) Co., Ltd
  • 7.2. Sino-Swed Pharmaceutical Corp. Ltd
  • 7.3. Fresenius Kabi (Sweden) Co., Ltd
  • 7.4. B.Braun AG (Germany)

8. Market Outlook of Fat Emulsion in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Charts

  • Chart Patent Information of Fat Emulsion in China
  • Chart Some Approval Information of Fat Emulsion in China
  • Chart Fat Emulsion Sales in China
  • Chart Sales Value of Fat Emulsion in China, 2010-2014
  • Chart Sales Value of Fat Emulsion in Some Regions in China, 2010-2014
  • Chart Sales Volume of Fat Emulsion in China, 2010-2014
  • Chart Sales Volume of Fat Emulsion in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Fat Emulsion Manufacturers for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Fat Emulsion Made by Sino-Swed in China, 2010-2014
  • Chart Sales Value and Market Share of Fat Emulsion Made by Fresenius Kabi (Sweden) in China, 2010-2014
  • Chart Sales Value and Market Share of Fat Emulsion Made by Baxter Healthcare (Guangzhou) in China, 2010-2014
  • Chart Sales Value and Market Share of Fat Emulsion Made by B.Braun (Germany) in China, 2010-2014
  • Chart Sales Value and Market Share of Fat Emulsion Made by Fresenius Kabi (AT) in China, 2010-2014
  • Chart Sales Value and Market Share of Fat Emulsion Injection in China, 2010-2014
  • Chart Sales Volume and Market Share of Fat Emulsion Tablet in China, 2010-2014
  • Chart Price of Fat Emulsion Made by Baxter Healthcare (Guangzhou) in Some Chinese Cities in 2014
  • Chart Price of Fat Emulsion Made by Sino-Swed in Some Chinese Cities in 2014
  • Chart Price of Fat Emulsion Made by B.Braun (Germany) in Some Chinese Cities in 2014
  • Chart Price of Fat Emulsion Made by Fresenius Kabi (Sweden) in Some Chinese Cities in 2014
  • Chart Price of Fat Emulsion Made by Fresenius Kabi (AT) in Some Chinese Cities in 2014
Back to Top